Get the Stockscreener App
28.91
1.33%
0.38
Artivion Inc stock is traded at $28.91, with a volume of 497.25K.
It is up +1.33% in the last 24 hours and up +20.71% over the past month.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
See More
Previous Close:
$28.53
Open:
$28.52
24h Volume:
497.25K
Relative Volume:
0.98
Market Cap:
$996.26M
Revenue:
$384.90M
Net Income/Loss:
$-851.00K
P/E Ratio:
-1,445.50
EPS:
-0.02
Net Cash Flow:
$12.83M
1W Performance:
+23.92%
1M Performance:
+20.71%
6M Performance:
+0.70%
1Y Performance:
+23.55%
1-Day Range:
$28.27
$29.26
1-Week Range:
$23.14
$29.26
52-Week Range:
$21.97
$32.33
Artivion Inc Stock (AORT) Company Profile
Name
Artivion Inc
Sector
Industry
Phone
(770) 419-3355
Address
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
28.91 | 996.26M | 384.90M | -851.00K | 12.83M | -0.02 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-24 | Initiated | JMP Securities | Mkt Outperform |
| Sep-27-22 | Reiterated | Lake Street | Buy |
| Aug-08-22 | Initiated | Lake Street | Buy |
| Mar-03-22 | Initiated | Stifel | Buy |
Artivion Inc Stock (AORT) Latest News
Artivion, Inc. (NYSE:AORT) Receives $31.40 Consensus PT from Brokerages - Defense World
CryoLife Stock Soars to 52-Week High, Hits $30.62 - MSN
Artivion, Inc.'s (NYSE:AORT) 29% Jump Shows Its Popularity With Investors - simplywall.st
Artivion (NYSE:AORT) Raised to “Strong-Buy” at Citizens Jmp - Defense World
Artivion, Inc. (NYSE:AORT) Q1 2025 Earnings Call Transcript - MSN
Artivion revenue increases 2% to USD 99M in Q1 2025 - Medical Buyer
Artivion’s Earnings Call: Optimism Amid Challenges - TipRanks
ARTIVION, INC. SEC 10-Q Report - TradingView
Artivion (AORT) Maintains Market Outperform Rating by JMP Securities | AORT Stock News - GuruFocus
JMP maintains Artivion stock Market Outperform, $33 target - Investing.com
What Analysts Are Saying About Artivion Stock - Benzinga
Artivion, Inc.'s (NYSE:AORT) CEO Looks Like They Deserve Their Pay Packet - simplywall.st
Artivion (AORT) Receives Reiteration of 'Buy' Rating from Needha - GuruFocus
Artivion (AORT) Receives Reiteration of 'Buy' Rating from Needham | AORT Stock News - GuruFocus
Artivion Announces Presentation of New Clinical Data from NEXUS - GuruFocus
Stifel maintains Artivion stock Buy rating, $30 target amid growth By Investing.com - Investing.com India
Stifel maintains Artivion stock Buy rating, $30 target amid growth - Investing.com
Artivion Inc. Reports Q1 2025 Financial Results - TipRanks
Artivion Inc (AORT) Q1 2025 Earnings Call Highlights: Strong Product Growth Amid Cybersecurity ... - Yahoo Finance
Artivion Inc (AORT) Q1 2025 Earnings Call Highlights: Strong Pro - GuruFocus
Artivion (AORT) Reports Q1 2025 Growth and Raises Full-Year Guid - GuruFocus
Artivion: Q1 Earnings Snapshot - MySA
Artivion Inc (AORT) Q1 2025 Earnings: EPS of $(0.01) Beats Estimate, Revenue Surpasses Expectations at $99 Million - GuruFocus
Earnings call transcript: Artivion Q1 2025 revenue misses forecast, stock rises - Investing.com
Artivion (AORT) Lags Q1 Earnings Estimates - Yahoo Finance
Artivion Q1 2025 slides: Revenue grows 4% as cyber incident recovery accelerates - Investing.com India
Artivion’s (NYSE:AORT) Q1: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
Artivion (AORT) Raises Revenue Outlook for 2025 | AORT Stock New - GuruFocus
Artivion Reports First Quarter 2025 Financial Results | AORT Sto - GuruFocus
Artivion Q1 2025 slides: Revenue grows 4% as cyber incident recovery accelerates By Investing.com - Investing.com South Africa
Artivion earnings beat by $0.06, revenue fell short of estimates - Investing.com UK
Artivion Reports First Quarter 2025 Financial Results - Star Local Media
Artivion (AORT) Shares Promising Clinical Data from Nexus Triomp - GuruFocus
Artivion (AORT) Shares Promising Clinical Data from Nexus Triomphe Trial | AORT Stock News - GuruFocus
Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting - PR Newswire
Artivion (AORT) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Artivion (AORT) to Release Quarterly Earnings on Monday - Defense World
Artivion: Q4 Earnings Snapshot - Barchart.com
Artivion Inc (AORT) Q1 2025 Earnings Report Preview: What To Loo - GuruFocus
Wells Fargo & Company MN Buys 6,299 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Artivion (NYSE:AORT) rises 5.3% this week, taking three-year gains to 16% - simplywall.st
LPL Financial LLC Grows Stock Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results | AORT Stock News - GuruFocus
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results - Kilgore News Herald
JPMorgan Chase & Co. Increases Stake in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Shares Sold by Geode Capital Management LLC - Defense World
Franklin Resources Inc. Buys 600 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Russell Investments Group Ltd. Acquires 16,720 Shares of Artivion, Inc. (NYSE:AORT) - The AM Reporter
Unpacking Q4 Earnings: Artivion (NYSE:AORT) In The Context Of Other Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks - Yahoo Finance
Investors in Artivion (NYSE:AORT) have seen returns of 15% over the past year - Yahoo Finance
Arrowstreet Capital Limited Partnership Invests $288,000 in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion Inc Stock (AORT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):